Filing metadata

Accession number
0001062993-21-001198
Form type
Form 4
Filer
Trillium Therapeutics Inc.
CIK
CIK 1616212
Filed
Feb 10, 2021
Reporting period
Feb 08, 2021
Description
Insider transaction

Explore SEC Filings Hub